HOLLY MARTIN: Open Payments
NPI 1760488035 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 41 payments from 14 companies in 2025. Trend: 2023 $970 · 2024 $650 · 2025 $784
Food & beverage: $784
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $138 |
| UCB, Inc. | 4 | $112 |
| Galderma Laboratories, L.P. | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 4 | $76 |
| Amgen Inc. | 4 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| Arcutis Biotherapeutics, Inc. | 3 | $65 |
| Botanix SB Inc | 2 | $33 |
| Organon LLC | 3 | $27 |
| LEO Pharma Inc. | 1 | $24 |
Products named: Bimzelx, Sotyktu, OTEZLA, Zoryve, SKYRIZI, NEMLUVIO, RINVOQ, SOFDRA.
Industry payments across NC — which companies pay providers there.
